Delfini Logo
Evidence- and Value-based Solutions for Health Care™
Clinical Improvement Consults, Content Development, Training & Seminars, Tools

Critical Appraisal Intensive

McKesson Decision-support Teams

The EBM Information Quest: Is it true? Is it useful? Is it usable?™

Delfini Co-founders: Michael E Stuart MD, President & Medical Director . Sheri Ann Strite, Managing Director & Principal

Quick Picks

Delfini: Dr. Michael E. Stuart & Sheri Ann Strite
Why Critical Appraisal Matters



Delfini Group Publishing

Contact Us
Updates & Contact Info

Free Online Tools

Free Online Tutorial

Delfini Blog

EBM Dolphin
Evidence & Quality Improvement Commentaries


Follow & Share...

Just-in-time UpdatesFollow Delfini Group on Twitter

Like Us Like Us on Facebook  Find UsFind Us at LinkedIn


"Two thumbs up for Delfini !! The recent EBM refresher and advanced EBM training they provided to over 40 McKesson content development clinicians received great reviews from our whole team. The refresher reinforced the expertise we have developed in applying the principles of critical appraisal to our clinical content development since we first started working with Delfini four years ago. Sheri and Mike’s ability to explain complex concepts in an easy to understand and conversational manner produced multiple “aha” moments for our team. Warm thoughts and wishes, Kate"
Kate Flanagan-Helmes, Director, Clinical Development, InterQual Products

Contact us for conference information if you would like to host a conference like this one.


DelfiniGram™: GET ON OUR UPDATE LIST Contact Us

Clinical Content Development Training Intensive 2006 & Intensive EBM Seminar 2010 Update

McKesson Logo




Mission: Help advance evidence-based medicine in the world’s leading healthcare services company and largest provider of clinical decision support solutions, and help provide solutions for creating decision support where evidence is lacking.

Concept: Evaluate work processes and flow. Make recommendations for rigor and efficiency. Provide an intensive critical appraisal training experience to advance knowledge and skills of content developers to help create rigorous scientific reviews. Conduct the evidence-based medicine training and provide support using methods to help ensure sustainability.

Outcomes: Medical literature evaluation training was provided for six full days in three stages of 2 days each over the course of a month and a half, with opportunities for staff to apply their skills and raise questions in between sessions. A post-test was immediately administered folowing the training intensive, which resulted in high scores of over 90 percent correct, reflecting good understanding of basic EBM concepts such as bias, confounding and chance.

Following the training, leadership and staff saw the value of applying an evidence-based approach and to that end, began an EBM initiative to implement and nurture an evidence-based process within their organization. See the press release below.

Most Recent
May 2010 EBM Intensive: The McKesson staff truly wowed us! We knew they created their own internal training program including an EBM working group, newsletters, training materials and regular training sessions, but it was so impressive to return to work with them and to see how grounded they are in EBM principles of critical appraisal. We were invited back in May 2010 to do an advanced seminar for them. We knew from prior experience with them what a committed and hard-working group this was. It was incredible to engage with them at such a high level. We would place them as among the best doing this work we have seen. Special thanks to visionary, Kate Flanagan-Helmes, who strives for the best for patients and her staff, to EBM coach extraordinare, Teresa Benson, and master at making things happen, Suzanne King.

In September 2006, an EBM post-test was again conducted. This was over six months since the 2006 training intensive. As a group, staff scored an impressive 94.7% — a solid "A" performance! This serves both as a testament to the fact that EBM training can work, plus it speaks to the incredible dedication of the McKesson staff to an evidence-based process. Refreshers and more in depth training are being planned by the McKesson EBM team.

March 2007: Decision support can enhance patient care: use of research-based guidelines will complement addiction professionals' decision-making. (Feature) From: Addiction Professional | Date: 3/1/2007 | Author: Dubiel, Lollie

To access, copy the following into an internet search engine:

At McKesson CA Intensive

EBM Delfini boat

Read Our Blog...

Use of our website implies agreement to our Notices. Citations for references available upon request.

Best of Delfini
What's New


Delfini Group Publishing
Sample Projects
About Us & Our Work
Site Search

Contact Info/Updates


Quick Navigator to Selected Resources



Marian Mostovy
McKesson Health Solutions

McKesson Solidifies InterQual® Criteria’s Leadership with Major Quality Milestones

Delfini Training Raises Evidence-Based Medical Content Standards, More Than 800 Clinical Experts Add Real-World Expertise to Development Process

NEWTON, Mass. — July 27, 2006 — McKesson Corporation, the world’s leading healthcare services company and largest provider of clinical decision support solutions, has achieved two major quality milestones with its InterQual® Criteria, making the InterQual solutions suite the unchallenged leader in evidence-based, clinical knowledge resources. McKesson further enhanced its time-tested InterQual development methodology with comprehensive training by the Delfini Group on the critical appraisal of evidence-based clinical information. In addition, the national panel of practicing clinical consultants for InterQual now totals more than 800.

The Delfini Group consists of world-renowned experts in the concepts, methods and skills of evidence-based clinical improvement to achieve better outcomes and additional value in clinical care. According to Michael Stuart, M.D., Delfini president, putting evidence-based medicine into practice is challenging not only because of the volume of scientific articles published each year — about 40,000 per month — but also, Delfini Group’s experience reveals that about 90 percent of those articles are either invalid or do not have clinically useful outcomes.

“A critical first step in developing evidence-based medical criteria is a thorough and consistent appraisal of the scientific literature, yet few clinicians or other allied health professionals receive in-depth training on how to determine how close to the truth that science is or how clinically useful those results are going to be,” explained Sheri Ann Strite, Delfini principal and managing partner. “McKesson has made an incredible investment in this training. It was one of the most intense experiences that we’ve put any company through. We are so impressed by McKesson’s commitment to maintaining a truly comprehensive process and providing the best in evidence-based information to their customers — and to improving healthcare in general.”

Complementing the McKesson criteria development team of 20 expertly trained healthcare professionals is an unrivaled pool of over 800 practicing clinical consultants. These consultants — physician specialists, nurses, psychologists, chiropractors, acupuncturists, social workers and occupational therapists — come from all areas of the United States, as well as Canada and Britain, and lend their practical knowledge and experience to the criteria development process, filling in gaps that the evidence does not adequately cover.

“Our development process has been consistently enhanced over the 30-year history of InterQual, to the point that we feel the gold standard in clinical-decision support criteria has officially gone platinum,” said Ricardo Guggenheim, M.D., vice president of clinical content and design, McKesson Health Solutions. “Our unique synthesis of best scientific evidence and real-world best practices ensures that our customers have optimal tools to support sound clinical decision-making.”

More than 3,500 health plans, hospitals, academic medical centers, government agencies and care management organizations serving more than 100 million people currently use InterQual evidence-based tools to support clinical decisions for individual patients across the continuum of care. The product’s unmatched breadth and clinical strength — including its rich research base, care facilitation features, integration of quality indicators and care management notes — has made InterQual Criteria the world’s most respected evidence-based medical solution for care management decision-making.

About McKesson Corporation
McKesson Corporation (NYSE: MCK), currently ranked 16th on the FORTUNE 500, is a healthcare services and information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes and improving the quality and safety of patient care. Over the course of its 173-year history, McKesson has grown to provide pharmaceutical and medical-surgical supply management across the spectrum of care; healthcare information technology for hospitals, physicians, homecare and payors; hospital and retail pharmacy automation; and services for manufacturers and payors designed to improve outcomes for patients. For more information, visit us at

More related press:

  • April 3, 2007
    To access, copy the following into an internet search engine:


Contact UsCONTACT DELFINI Delfini Group EBM DolphinDelfini Group EBM Dolphin

Return to Top

© 2002-2020 Delfini Group, LLC. All Rights Reserved Worldwide.
Use of this website implies your agreement to our Notices.

EBM Solutions for Evidence-based Health Care Quality